Related Experiment Video
Updated: May 10, 2026
06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations
J Soblet1, N Limaye, M Uebelhoer
1Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Molecular Syndromology
|June 27, 2013
Summary
Researchers identified new TIE2 gene mutations in sporadic venous malformations (VMs). These findings advance understanding of the genetic causes of common vascular anomalies, aiding future diagnostics and treatments.
Area of Science:
- Genetics
- Vascular Biology
- Dermatology
Background:
- Venous malformations (VMs) are common vascular anomalies.
- A rare familial form (VMCM) is linked to TIE2 mutations.
- Sporadic VMs are increasingly associated with somatic TIE2 mutations.
Purpose of the Study:
- To investigate the spectrum of TIE2 mutations in sporadic venous malformations.
- To identify novel somatic mutations in the TIE2 gene causing sporadic VMs.
Main Methods:
- Direct sequencing of the TIE2 coding region in cDNA from resected VM samples.
- Analysis of 30 sporadic VM samples for TIE2 mutations.
Main Results:
- TIE2 mutations were detected in 56.7% (17/30) of sporadic VM samples.
- Seven novel somatic intracellular TIE2 mutations were identified.
- Three of the novel mutations resulted in premature protein truncation.
Conclusions:
- Somatic TIE2 mutations are a significant cause of sporadic venous malformations.
- The identified mutations provide further insight into the molecular mechanisms of VM development.
- Discovery of novel mutations may inform targeted therapeutic strategies for VMs.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:26Varicose Veins I: Introduction
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...